Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $20.7700 (1.86%) ($20.4100 - $20.9800) on Wed. Aug. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.44% (three month average) | RSI | 41 | Latest Price | $20.7700(1.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 1.5% a day on average for past five trading days. | Weekly Trend | TGTX declines -4.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(63%) ARKG(58%) ARKK(56%) IWO(56%) IBB(55%) | Factors Impacting TGTX price | TGTX will decline at least -2.22% in a week (0% probabilities). VIXM(-34%) VXX(-32%) UUP(-18%) DRIV(-5%) XLC(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.22% (StdDev 4.44%) | Hourly BBV | 0 () | Intraday Trend | 0.5% | | | |
|
1 - 5 Day Possible Target | $8.58(-58.69%) | Resistance Level | $21.58 | 5 Day Moving Average | $20.31(2.26%) | 10 Day Moving Average | $20.51(1.27%) | 20 Day Moving Average | $21.58(-3.75%) | To recent high | -14% | To recent low | 24.4% | Market Cap | $2.631b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |